Clinical Trial Update: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating busulfan plus clofarabine followed by allogeneic hematopoietic stem cell transplantation for leukemia and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Leukemia
• Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-07